First Gene-Editing Human Trial Conducted in China
China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject that was suffering from metastatic lung cancer. The method used, will enable scientists to cut out a piece of DNA from living cell for modification and subsequently boost the immune system by injecting modified cells back into the body. The study